Enduring Material

Kansas 4M is a Geriatrics Workforce Enhancement Program (GWEP) supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). The award provided 100% of total costs and totaled $5 million with funding from 07/01/2024 through 06/30/2029. The contents are those of the author(s) and do not necessarily reflect the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government. For more information visit HRSA.gov.

• Describe the Kansas 4M Geriatrics Workforce Education Program.
• Discuss the evidence-based Age-Friendly Health Systems (4Ms) Framework.
• Explain the outcomes and business case for adopting the 4Ms.
• Share opportunities to participate in Kansas 4M educational programs and activities.

• The University of Kansas Medical Center designates this enduring material for a maximum of 0.75 Attendance w/ No Credit.
• The University of Kansas Medical Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The University of Kansas Medical Center designates this activity for a maximum of 0.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Module #0 (Collection of Learner Demographics) must be completed prior to viewing this content. Review/view the content, complete the post-test, and complete an evaluation before moving on! If you have any questions, please reach out to [email protected].

Teri Kennedy, PhD, MSW, ACSW, FGSA, FNAP has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Teri Kennedy, PhD, MSW, ACSW, FGSA, FNAP, Amy Berkley, RN, Jessica Kalender-Rich, MD, MHA, CMD, AGSF, Kathryn Krueger, MPH, CPH, and Molly Brown, PhD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

75 %

100 %

2/26/2025